Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands

Treatment options for ADHD in the Netherlands have increased with the introduction of the extended-release formulations of methylphenidate (MPH ER, Concerta(®)) in 2003 and atomoxetine (ATX, Strattera(®)) in 2005, but data on the effect on drug usage patterns are scarce. The objective of the present...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: van den Ban, Els, Souverein, Patrick C., Swaab, Hanna, van Engeland, Herman, Egberts, Toine C. G., Heerdink, Eibert R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Vienna 2010
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3000908/
https://ncbi.nlm.nih.gov/pubmed/21258431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12402-010-0044-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller